Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03550495 · ClinicalTrials.gov registry record · NA
A Multidisciplinary Delirium Prevention Strategy Involving Psychiatry in the ICU
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT03550495 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 104 participants.
The verdict
NCT03550495, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
Delirium affects up to 80% of intensive care unit (ICU) patients and is associated with longer hospital stays, increased morbidity and mortality, and increased costs. There is no FDA-approved treatment for delirium; the most effective strategy is prevention by nonpharmacological methods. The investigators propose to study a comprehensive delirium prevention bundle that has been effective against delirium in preliminary studies in elderly in-hospital patients and elderly ICU patients. This delirium prevention bundle includes the novel addition of psychiatrists to daily ICU rounds, as these professionals are specially trained to screen for latent mental illness and provide treatment for these illnesses. The effects of daily psychiatric evaluation of ICU patients has never been systematically studied, as ICU professionals are well-equipped to manage ICU delirium. Psychiatric consultation is reserved for severe and/or refractory cases of delirium. The investigators hypothesize that a multidisciplinary rounding approach including psychiatry within the ICU team will help diagnose psychiatric components that may contribute to delirium at an earlier time point, and thus can reduce the incidence and duration of delirium. The investigators also hypothesize that the proposed multidisciplinary approach will shorten hospital and ICU lengths of stay, duration of mechanical ventilation, and decrease in-hospital mortality.
Interventions
- BEHAVIORAL psychiatry involvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03550495
The ClinicalTrials.gov registry entry for NCT03550495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which psychiatry involvement is the first listed.
NCT03550495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03550495 about?
NCT03550495 is a clinical study titled "A Multidisciplinary Delirium Prevention Strategy Involving Psychiatry in the ICU". Delirium affects up to 80% of intensive care unit (ICU) patients and is associated with longer hospital stays, increased morbidity and mortality, and increased costs. There is no FDA-approved treatment for delirium; the most effective strategy is prevention by nonpharmacological methods. The investi...
What is the current status of trial NCT03550495?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2018-04-16. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03550495?
The interventions under investigation include: psychiatry involvement (BEHAVIORAL).
Who is sponsoring clinical trial NCT03550495?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.